Equites Radar

CG · The Carlyle Group Inc.

Asset ManagementUnited StatesAnalyst view: Buy

$44.41

+0.75% last session

End-of-day data · updated 2026-07-25

Bearish1 bullish · 4 bearish technical signals
Consensus: Buy (2.24 from 17 analysts)
To mean target: +25.2%

Market cap

$16B

Enterprise value

$30B

Trailing P/E

30.5

Forward P/E

8.9

Dividend yield

3.0%

Beta

1.83

Avg volume

3M

Employees

2K

2D change

2.23%

5D change

1.48%

10D change

-1.54%

30D change

8.35%

60D change

-0.55%

MTD change

7.25%

YTD change

-22.13%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)2.24
Covering analysts17
Mean price target$55.59
Low price target$44.00
Upside to mean target+25.2%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)49.4
50-day MA$44.74
200-day MA$51.67
Price vs 50-day MA-0.7%
Price vs 200-day MA-14.1%
MACD histogram0.11
Volume vs 3-month avg0.8×
52w low $40.5252w high $67.95

Analyst sentiment over time — CG

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-13

Latest call per bank · past 12 months

RBC Capital

Sector Perform

$56.00

+26.1% vs price
▼ cut from $58.00Maintains · 2026-07-13

Barclays

Overweight

$57.00

+28.3% vs price
▼ cut from $63.00Maintains · 2026-07-09

JP Morgan

Neutral

$63.00

+41.9% vs price
▼ cut from $66.00Maintains · 2026-05-08

Morgan Stanley

Equal-Weight

$66.00

+48.6% vs price
▼ cut from $71.00Maintains · 2026-04-21

Goldman Sachs

Buy

$69.00

+55.4% vs price
▼ cut from $81.00Maintains · 2026-04-07

UBS

Buy

$65.00

+46.4% vs price
▼ cut from $81.00Maintains · 2026-02-20

Citigroup

Buy

$71.00

+59.9% vs price
▼ cut from $74.00Maintains · 2025-11-03

Jefferies

Hold

$66.00

+48.6% vs price
▲ raised from $54.00Maintains · 2025-08-13

Recent rating actions

DateFirmActionRatingPrice target
2026-07-13Evercore ISI GroupMaintainsIn-Line$56.00 $48.00
2026-07-13RBC CapitalMaintainsSector Perform$58.00 $56.00
2026-07-09BarclaysMaintainsOverweight$63.00 $57.00
2026-07-09CitizensMaintainsMarket Outperform$75.00 $70.00
2026-05-18TD CowenMaintainsHold$53.00 $50.00
2026-05-08TD CowenDowngradeBuyHold$54.00 $53.00
2026-05-08JP MorganMaintainsNeutral$66.00 $63.00
2026-05-08BarclaysMaintainsOverweight$67.00 $63.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-23

  • RSI (14): RSI is 49 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 0.7% below the 50-day MA ($44.74).
  • Price vs 200-day MA: Trading 14.1% below the 200-day MA ($51.67).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is positive (+0.11) — short-term momentum is improving.
  • 52-week range: Price is within 10% of the 52-week low ($40.52).

CG Price Chart

Loading chart for CG

Fundamentals

Revenue (TTM)$3.0B
EBITDA
Free cash flow
Operating cash flow-$4.0B
Book value / share$15.02
Net debt / EBITDA
WACC12.0%
Revenue growth-94.00%
Earnings growth

About The Carlyle Group Inc.

The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES, recapitalization. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies, supply chains, aftermarket services, cybersecurity and digital resilience, digital transformation. Within healthcare, biotech and medtech innovation, life sciences, healthcare IT, pharmacy, pharma commercialization. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, Hong Kong, South East Asia, Indonesia, Philippines, Malaysia, Singapore, Vietnam, Taiwan, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $2.24 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $50 million and $300 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices across North America, South America, Asia, Australia and Europe.

More in Asset Management

Screen CG against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.